Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Ballard

Showing results (461-470 of 480) with videos related to

Pageof 48
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 12, 2025
Randomized phase 2a trial assessing a novel septin molecular glue in Alzheimer's diseaseMieke Nuytten, Marieke Voets, Eveline Debroux, et al.
The Journal of Prevention of Alzheimer'S Disease|April 18, 2026
Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control dataBjoern O Schelter, Helen Shiells, Serena Lo, et al.
Age and Ageing|November 16, 2020
Mild cognitive impairment: the Manchester consensusRoss A Dunne, Dag Aarsland, John T O'Brien, et al.
Frontiers in Public Health|October 7, 2022
Parallel randomized controlled feasibility trials of the "Active Brains" digital intervention to protect cognitive health in adults aged 60-85Rosie Essery, Sebastien Pollet, Katherine Bradbury, et al.
The Lancet. Neurology|March 19, 2016
Defeating Alzheimer's disease and other dementias: a priority for European science and societyBengt Winblad, Philippe Amouyel, Sandrine Andrieu, et al.
Plos One|June 30, 2017
Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendationsLucy Webster, Derek Groskreutz, Anna Grinbergs-Saull, et al.
Trials|April 5, 2019
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Trials|July 21, 2020
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Neurology|April 4, 2020
Research criteria for the diagnosis of prodromal dementia with Lewy bodiesIan G McKeith, Tanis J Ferman, Alan J Thomas, et al.
The Journal of Prevention of Alzheimer'S Disease|January 22, 2026
Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's diseaseClaude M Wischik, Richard Stefanacci, Peter Bentham, et al.
Pageof 48

Showing results (461-470 of 480) with videos related to

Sort By:
Pageof 48
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 12, 2025
Randomized phase 2a trial assessing a novel septin molecular glue in Alzheimer's diseaseMieke Nuytten, Marieke Voets, Eveline Debroux, et al.
The Journal of Prevention of Alzheimer'S Disease|April 18, 2026
Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control dataBjoern O Schelter, Helen Shiells, Serena Lo, et al.
Age and Ageing|November 16, 2020
Mild cognitive impairment: the Manchester consensusRoss A Dunne, Dag Aarsland, John T O'Brien, et al.
Frontiers in Public Health|October 7, 2022
Parallel randomized controlled feasibility trials of the "Active Brains" digital intervention to protect cognitive health in adults aged 60-85Rosie Essery, Sebastien Pollet, Katherine Bradbury, et al.
The Lancet. Neurology|March 19, 2016
Defeating Alzheimer's disease and other dementias: a priority for European science and societyBengt Winblad, Philippe Amouyel, Sandrine Andrieu, et al.
Plos One|June 30, 2017
Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendationsLucy Webster, Derek Groskreutz, Anna Grinbergs-Saull, et al.
Trials|April 5, 2019
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Trials|July 21, 2020
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Neurology|April 4, 2020
Research criteria for the diagnosis of prodromal dementia with Lewy bodiesIan G McKeith, Tanis J Ferman, Alan J Thomas, et al.
The Journal of Prevention of Alzheimer'S Disease|January 22, 2026
Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's diseaseClaude M Wischik, Richard Stefanacci, Peter Bentham, et al.
Pageof 48